Regulations.gov document
Interim Response Letter from CDER to Gator Pharmaceuticals, Inc.
Other · FDA-2017-P-1104 · posted Nov 26, 2018
Key facts
| Document ID | FDA-2017-P-1104-0007 |
|---|---|
| Title | Interim Response Letter from CDER to Gator Pharmaceuticals, Inc. |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2017-P-1104 |
| Posted | Nov 26, 2018 |
| Comment period opens | Nov 26, 2018 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: